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Using atomic absorption spectrum analysis, we
found iron levels in exudates from chronic wounds
to be signi®cantly increased (3.71 6 1.56 mmol per g
protein) compared to wound ¯uids from acute
wounds derived from blister ¯uids (1.15 6 0.62 mmol
per g protein, p < 0.02), drainage ¯uids of acute
wounds (0.87 6 0.34 mmol per g protein, p < 0.002),
and pooled human plasma of 50 volunteers
(0.42 mmol per g protein). Increased free iron and an
increase in reactive oxygen species released from
neutrophils represent pathogenic key steps that ± via
the Fenton reaction ± are thought to be responsible
for the persistent in¯ammation, increased connective
tissue degradation, and lipid peroxidation contribut-
ing to the prooxidant hostile microenvironment of
chronic venous leg ulcers. We herein designed a
selective pick-up dressing for iron ions by covalently
binding deferoxamine to cellulose. No leakage
occurred following gamma sterilization of the
dressing and, more importantly, the deferoxamine-
coupled cellulose dressing retained its iron complex-
ing properties suf®cient to reduce iron levels found
in chronic venous ulcers to levels comparable to
those found in acute wounds. In order to study the
functionality of the dressing, human dermal ®bro-
blasts were exposed to a Fenton reaction mimicking
combination of 220 mM Fe(III) citrate and 1 mM
ascorbate resulting in a 4-fold induction of
matrix-degrading metalloproteinase 1 as determined
by a matrix-degrading metalloproteinase 1 speci®c
enzyme-linked immunosorbent assay. This induction
was completely suppressed by dissolved deferox-
amine at a concentration of 220 mM or by an equi-
molar amount of deferoxamine immobilized to
cellulose. In addition, the Fe(III) citrate and ascor-
bate driven Fenton reaction resulted in an 8-fold
increase in malondialdehyde, the major product of
lipid peroxidation, as determined by high pressure
liquid chromatography. This increase in malondi-
aldehyde levels could be signi®cantly reduced in the
presence of the selective pick-up dressing coupled
with deferoxamine suggesting that the deferoxamine
dressing, in fact, prevents the development of a
damaging prooxidant microenvironment and also
protects from unfavorable consequences like matrix-
degrading metalloproteinase 1 and lipid peroxide
induction. Key words: chronic wounds/dressing/Fenton
reaction/Haber±Weiss reaction/iron/reactive oxygen species.
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C
hronic venous leg ulcers represent the ®nal outcome
of lower extremity chronic venous insuf®ciency in
most cases. It is a debilitating recurrent complication
with an estimated cost of 1 billion dollars annually in
the U.S.A. for its treatment. Moist wound healing
providing dressings in combination with compression therapy
represent the state-of-the-art ulcer treatment. Even though progress
has been achieved, current efforts de®ning the highly aggressive
chronic wound microenvironment promise further improvement
of this treatment modality.
Chronic leg ulcers fail to progress through the normal pattern of
wound repair involving in¯ammation, granulation tissue formation,
and remodeling, but instead remain in a chronic in¯ammatory state
with little signs of healing. There is increasing evidence that the
persisting in®ltration of neutrophils and macrophages (Rosner et al,
1995) in conjunction with elevated iron depositions in the ulcer
tissue (Ackerman et al, 1988) play a major role in the generation of
the prooxidant hostile microenvironment in chronic venous leg
ulcers. Venous hypertension results in enhanced erythrocyte
extravasation into the interstitium through widened interendo-
thelial pores (Wenner et al, 1980). Iron is released from hemoglobin
of degraded erythrocytes, ferritin, hemosiderin (Thomas et al, 1985;
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Biemond et al, 1988), aconitase, and other iron±sulfur proteins
(Fridovich, 1995) via the attack of reactive oxygen species (ROS)
and proteolytic enzymes occurring in nonhealing wounds.
Subsequently, iron in combination with hydrogen peroxide
released by activated neutrophils generates the highly toxic
hydroxyl radical via the Fenton reaction (Halliwell and
Gutteridge, 1989) Fe2+ + H2O2 ® Fe3+ + OH´ + OH±. The
resulting ferric iron (Fe3+) can be reduced to ferrous iron (Fe2+) in
the Haber±Weiss reaction involving superoxide anions:
Fe3+ + O2
±´ ® Fe 2+ + O2, thus perpetuating the Fenton reaction
and tissue damage. The hydroxyl radical initiates local lipid
peroxidation of polyunsaturated fatty acids in cellular membranes
resulting in an in¯ammatory response with continuous recruitment
of neutrophils (Gutteridge et al, 1979; Weiss, 1989; Cheatle, 1991;
Schaich, 1992; Falanga and Eaglstein, 1993).
In addition to direct damage of structural proteins of the
extracellular matrix (Monboisse and Borel, 1992), the hydroxyl
radical and other ROS enhance the synthesis and activity of matrix-
degrading metalloproteinases (Wysocki et al, 1993; Weckroth et al,
1996; Saarialho-Kere, 1998) and serine proteases with concomitant
inactivation of tissue inhibitors of matrix metalloproteinases (Mast
and Schultz, 1996) and serine proteases (Grinnell et al, 1992; Rao
et al, 1995; Grinnell and Zhu, 1996; Herrick et al, 1997) ®nally
tilting the balance towards proteolysis. Apart from enhanced
connective tissue degradation, serine proteases have been identi®ed
to degrade key growth factors in tissue repair such as platelet-
derived growth factor (Wlaschek et al, 1997; Yager et al, 1997) and
others.
The identi®cation of factors delaying wound healing has been
crucial for the development of a novel therapeutic concept that
®nally led to a new dressing concept called the selective pick-up
principle.2 According to this optimized concept, we focused on the
strategy to remove or eliminate the deleterious substances from the
wound exudate by selectively acting biomolecules that are bound
to the surface of traditional wound dressing materials instead of
applying potentially bene®cial agents to the wounds (Meyer-Ingold
et al, 1998; Edwards et al, 1999). This selective sequestration is
likely to result in a positive in¯uence on wound healing or even in
a reversal of this process from chronicity to healing. Furthermore, a
more general bene®t of selective pick-up dressings includes their
ability to adjust the composition of wound ¯uids locally compared
to the systemic action of drugs.
In a ®rst attempt to disrupt the detrimental sequence of events
leading to a prooxidant hostile microenvironment and impaired
healing ± and based on the herein reported ®nding of increased iron
concentrations in the exudate of chronic venous leg ulcers ± we
have designed and developed a ®rst prototype of a selective pick-up
dressing for iron ions based on the iron chelator deferoxamine
(DFO) covalently immobilized to a cellulose dressing.
The in vitro ef®cacy and functionality of the iron pick-up
dressing was demonstrated by its iron-complexing properties, and
its protective activity concerning the iron-driven upregulation of
matrix-degrading metalloproteinase 1 (MMP-1) and lipid peroxid-
ation in human dermal ®broblasts when subjected to different
in vitro settings simulating the hostile microenvironment of venous
leg ulcers.
MATERIALS AND METHODS
Cell culture Dermal foreskin ®broblasts were established by outgrowth
from biopsies of healthy human donors (Fleischmajer et al, 1981) at an
age of 3±6 y and cultured in Dulbecco's modi®ed Eagle's medium
supplemented with glutamine (2 mM), penicillin (400 U per ml),
streptomycin (50 mg per ml), and 10% fetal bovine serum in a
humidi®ed atmosphere of 5% CO2 and 95% air at 37°C. Cells were used
at passages 5±15 corresponding to cumulative population doubling rates
of 10±32 (Bayreuther et al, 1992).
Generation of ROS and the Fenton reaction The Fenton reaction
was simulated by exposure of con¯uent ®broblasts to concentrations of
220 mM Fe(III) citrate and 1 mM ascorbate in the presence or absence of
H2O2 in serum-free medium. Non-toxic concentrations of dissolved
DFO (220 mM), equimolar concentrations of DFO immobilized to
cellulose, and cellulose dressings without DFO were used for the
incubation. By means of the transwell chamber system (Costar,
Bodenheim, Germany) we avoided mechanical stress induced by direct
contact between cells and the dressing. Cytotoxicity was analyzed using
the MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide]
assay (Green et al, 1984). The viability of cells was more than 80% of
nontreated controls at the used concentrations of Fe(III) citrate,
ascorbate, dissolved DFO, and cellulose-coupled DFO. After a 4 h
exposure of ®broblasts to different treatment modalities, which was
performed in medium with or without serum, ®broblasts were washed
with phosphate-buffered saline and either fresh medium without serum
was added to determine the MMP-1 production after 24 h using a
MMP-1 speci®c enzyme-linked immunosorbent assay (ELISA), or
®broblasts were directly lyzed in water for the high pressure liquid
chromatography (HPLC) based measurement of malondialdehyde
(MDA), the major product of lipid peroxidation.
ELISA An MMP-1 ``sandwich'' ELISA assay was performed according
to the manufacturer's protocol (Amersham Pharmacia Biotech,
Braunschweig, Germany) using precoated 96-well immunoplates, rabbit
antihuman MMP-1 antibodies, and an antirabbit horseradish peroxidase
conjugate. 3,3¢,5,5¢-Tetramethylbenzidine was used as peroxidase
substrate. Optical densities were determined at 450 nm using a microtiter
plate reader LP 400 (Sano® Diagnostics Pasteur, Freiburg, Germany).
MMP-1 concentrations in the samples were determined against standard
curves using Graph Pad Software (San Diego, CA).
Measurement of thiobarbituric-acid-reactive substances Thio-
barbituric-acid-reactive substances were measured as described previously
(Yu et al, 1986) with minor modi®cations. Brie¯y, to 0.5 ml of cell
lysate, 20 ml 5% butylated hydroxytoluene, 0.35 ml 20% trichloroacetic
acid, and 0.5 ml 1.4% thiobarbituric acid were added. The mixtures
were incubated at 95°C for 15 min. Following centrifugation, the
samples were analyzed using HPLC on a 4 3 250 mm LiChrospher 100
RP-18 column with ¯uorescence detection. The mobile phase consisted
of 55% potassium phosphate (50 mM, pH 5.5) and 45% methanol.
Standard solutions of MDA (0.1±1 mM) were used for calibration. MDA
concentrations were expressed per mg protein. Protein was determined
using the Bradford assay (Biorad, Munich, Germany).
Collection of wound exudates and determination of total iron and
protein content Wound ¯uids were collected from chronic venous
leg ulcers of nine patients after coverage of the wounds with a
transparent polyurethane semiocclusive ®lm dressing (Cuti®lm,
Beiersdorf, Hamburg, Germany). After 30 min wound exudate was
aspirated through the ®lm dressing using a 30 G needle mounted on a
2 ml syringe. Acute wound exudate was obtained by drainage from four
patients who had undergone mastectomy and one patient after excision
of a myosarcoma, and from four patients by punctation of blisters from
bullous pemphigoid. In addition, pooled human plasma derived from 50
donors was analyzed. The ¯uids were centrifuged at 10,000 3 g, and
supernatants were stored frozen at below ±20°C before analysis. Only
clear yellow exudates were analyzed for total iron levels using atomic
absorption spectroscopy after microwave pressure disintegration with
nitric acid. This method requires at least 200 ml of ¯uid with a detection
limit of 1 ppm. The total protein content of each ¯uid was determined
using established procedures (Bradford, 1976).
Covalent coupling of DFO to cellulose dressing DFO was
covalently immobilized to a cellulosic support by using the 1,1¢-
carbonyldiimidazole (CDI) method (Hearn, 1987) yielding a stable
urethane bond. Brie¯y, the procedure comprises two steps: (i) activation
of the hydroxyl groups of cellulose support material (cotton gauze,
viscose fabric, or cellulose ®lm) was carried out with CDI in anhydrous
acetone for 2 h according to an earlier published method (Feldhoff,
1992); (ii) reaction of the CDI-activated cellulose with DFO mesylate
(Sigma, Deisenhofen, Germany) was performed as earlier described
(Feldhoff, 1992) except that 25 mM sodium bicarbonate solution,
pH 7.7, was used for 4 h. The extensively washed DFO±cellulose was
air-dried at room temperature and sterilized by gamma irradiation at
30 kGy. Depending on the cellulose matrix used, between 20 and
100 mmol DFO could be bound to 1 g of cellulose fabric. For the
production of placebo±cellulose all steps were carried out identically
without adding CDI and DFO.
2Meyer-Ingold W, Eichner W, Ettner N, Schink M: The composition
of chronic wound ¯uid can be modulated by a dressing. Wound Rep Reg 7,
A 281, 1999 (abstr.)
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Leakage studies on gamma-irradiated immobilized DFO The
stability of gamma-sterilized DFO±cellulose was examined by extracting
100 mg cellulose with 5 ml of either a methanol±water mixture (50:50
vol/vol) or physiologic solution (0.9% NaCl, 1 mM MgCl2, 1 mM
CaCl2) for 16 h at room temperature. The resulting extracts were
analyzed directly, in the case of methanol, or after solvent exchange by
solid phase extraction, in the case of physiologic extracts, by means of
liquid chromatography/mass spectrometry (LC/MS) with a detection
limit of 1 mg per ml for methanol extracts and 10 mg per ml for
physiologic extracts.
In a parallel set of experiments, dry pulverized DFO was gamma
irradiated (30 kGy) and subsequently analyzed for changes in its mass
pro®le by means of LC/MS.
A third approach was used for the detection of volatile breakdown
products of DFO± and placebo±cellulose before and after gamma
sterilization applying headspace gas chromatography/mass spectrometry
with a detection limit of 1±50 ppm. Three hundred and ®fty milligrams
of cellulose were equilibrated in gas-tight 20 ml vials at 80°C for 1 h.
Thereafter analysis of 1 ml of the resulting headspace atmosphere was
performed.
Determination of the amount of DFO coupled to cellulose (iron
pick-up assay) and measurement of the kinetics of iron binding In
order to determine the amount of functional DFO coupled to cellulose
an indirect method was established. Accordingly, 15 mg of cellulose
(placebo or verum) were incubated in 30 ml of a 150 mM FeSO4
solution (pH 5.6) for 19 h at 25°C by mixing the content of tubes
intensely on an overhead rotator (Heidolph REAX 2, Schwabach,
Germany). The concentration of iron (Fe2+ and Fe3+) in the
supernatants before and after addition of cellulose samples was
determined by means of the ready-to-use ferrozine-based assay MPR3
(Roche Diagnostics, Mannheim, Germany). This assay does not detect
DFO-bound iron. The amount of DFO coupled to cellulose was
calculated on the basis of the difference in iron concentration (D iron
concentration, mM) as DFO chelates iron stoichiometrically. The
resulting equation was: amount of immobilized DFO (mmol per g) =
iron binding capacity (mmol per g) = D iron concentration (mM) 3 2 ml
per g sample. The results were corrected by subtracting the amount of
unspeci®cally bound iron determined with placebo±cellulose. The results
were expressed in mmol per cm2 by multiplying the iron binding
capacity with the area weight (g per cm2).
The measurements of iron binding kinetics of gamma-sterilized DFO±
cellulose were performed with slight modi®cations using an FeSO4
solution at a concentration of about 50 mM and adding 40 ml iron
solution per 15 mg cellulose sample (ratio DFO:Fe = 1.5:2.0). Samples
were mixed intensely by overhead rotation at room temperature and
iron concentrations were determined in the supernatants at de®ned time
intervals.
In order to evaluate potential protein effects on the iron binding
characteristics of DFO±cellulose a third setting was used: 50 mg
(= 1.6 cm2) of gamma-sterilized cellulose dressing (placebo or verum)
were added to 1.33 ml of a 49.6 mM FeSO4 solution supplemented with
30 mg per ml bovine serum albumin (BSA) (albumin fraction V, Merck,
Darmstadt, Germany). After a 24 h period of intense mixing at 25°C,
the iron concentration in the supernatants was determined as described
above.
RESULTS
Iron is substantially increased in ¯uids derived from chronic
venous leg ulcers compared to acute wounds or human
plasma Total iron levels in nine exudates from patients suffering
from chronic venous leg ulcers ranged between 56.2 and 182 mM
with a mean of 110 mM and standard deviation of 42 mM. In order
to compensate for different protein contents the values were related
to grams of protein. Accordingly, iron levels in chronic wound
¯uids ranged between 1.86 and 5.7 mmol per g protein with a mean
of 3.71 mmol per g protein and a standard deviation of 1.56 mmol
per g protein (Fig 1). Substantially lower iron levels were found in
pooled human plasma (21.8 mM Fe and 0.42 mmol Fe per g
protein, respectively), in acute wound exudates from blisters of four
patients (35.8 6 0.7 mM Fe and 1.15 6 0.62 mmol Fe per g
protein, respectively), and in ®ve drainage ¯uids (23.5 6 9.3 mM
Fe and 0.87 6 0.34 mmol Fe per g protein, respectively).
Effective reduction of iron ions from iron solutions by the
gamma-sterilized DFO±cellulose dressing In order to assess
the in vitro ef®cacy of the DFO±cellulose, the kinetics of iron
uptake from a solution of 47 mM FeSO4 by pieces of gamma-
sterilized DFO±cellulose dressing was studied (DFO:Fe ratio
1.55:2.00) (Fig 2). The DFO dressing reduced the iron
concentration in the BSA-free supernatant in a time-dependent
manner by 50% after 6 h of incubation and 80% after 24 h. This
corresponds to 93% of the total iron-binding capacity of the above
speci®ed cellulose. By contrast, no decrease in iron concentration
was found up to 24 h for the same amount of control placebo
dressing without DFO. When the DFO:Fe ratio was changed to
3.7:1, a 50% reduction was already achieved after 10 min, a 90%
reduction after 30 min of incubation, and a 98% reduction of the
initial iron concentration after 24 h of incubation. In order to
demonstrate the ability of the iron pick-up dressing to remove iron
ions also in the presence of protein, placebo or DFO-coupled
cellulose was incubated in a BSA-containing FeSO4 solution with a
protein:cellulose ratio of 25 mg per cm2. This test design mimics
the conditions in chronic wound ¯uids concerning protein, total
iron concentration, and the maximal volume of exudate produced
in leg ulcers, which is 1.2 ml per cm2 wound area in 24 h (Thomas
et al, 1996). After a 24 h period of incubation, the initial iron
concentration was reduced in the presence of BSA alone by 23%, in
the placebo-containing sample by 25%, and in case of the DFO-
coupled dressing by 99.5%.
DFO and DFO±cellulose withstand gamma irradiation Gamma-
sterilized DFO±cellulose was subjected to two different extraction
solvents and these extracts were analyzed using the highly sensitive
method of LC/MS. Neither DFO nor its breakdown products could
be detected. Furthermore, no change in the chemical structure of
gamma-irradiated dry pulverized DFO was detectable, which would
be identi®ed by a different mass pro®le. In addition, no volatile
breakdown products of DFO±cellulose before and after gamma
sterilization were found. The iron-binding capacity of DFO±
cellulose decreased negligibly after gamma irradiation as determined
by means of the iron pick-up assay (data not shown).
Dissolved and cellulose-coupled DFO reduced the iron-
driven induction of interstitial collagenase (MMP-1) We
here established an in vitro model closely simulating the Fenton and
Haber±Weiss reactions occurring in chronic venous leg ulcers. For
Figure 1. Total iron levels are signi®cantly increased in chronic
wound exudates compared to acute wound exudates and human
plasma. Wound ¯uids were collected from chronic venous leg ulcers of
nine patients, four patients who had undergone mastectomy, and one
patient after surgical removal of a myosarcoma, and from blister ¯uids
from four patients with bullous pemphigoid as detailed in Materials and
Methods. Total iron content of each ¯uid and a sample of human plasma
pooled from 50 donors was determined using atomic absorption
spectrum analysis and expressed as mmol Fe per g protein. Data are
shown as mean values with standard deviation. Signi®cance was
calculated using the Wilcoxon, Mann and Whitney U test (p < 0.02 ±
blister ¯uids; p < 0.002 ± drainage ¯uids, compared to chronic wound
¯uids).
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this purpose human dermal ®broblasts were incubated with
220 mM Fe(III) citrate and 1 mM ascorbate in the presence of
DFO (220 mM) dissolved in PBS, an equimolar amount of DFO
coupled to cellulose, and control cellulose without DFO as detailed
in Materials and Methods. We have used Fe(III) citrate
concentrations in this in vitro model that relate to the upper range
of Fe concentrations found in ¯uid from chronic wounds. Exposure
of human dermal ®broblast monolayer cultures to Fe(III) citrate and
ascorbate resulted in a 3-fold induction of the MMP-1 protein
concentration compared to the mock-treated control. Exogenous
addition of H2O2 did not further enhance this induction, most
probably indicating that intracellular H2O2 levels are suf®cient to
drive the Fenton reaction (data not shown). This induction of
MMP-1 could be suppressed by 75% in the presence of dissolved
DFO at a concentration of 220 mM (Fig 3A). Similar results were
observed in the presence of 10%-serum-containing medium during
the incubation with Fe(III) citrate (data not shown) indicating that
the effect of Fe(III) citrate on MMP-1 induction is independent of
serum. DFO-coupled cellulose suppressed the MMP-1 induction
in human dermal ®broblasts by 80% of the control cellulose.
Interestingly, addition of DFO±cellulose even at 2 h after initiating
the Fenton reaction with Fe(III) citrate and ascorbate resulted in an
almost complete inhibition of the MMP-1 induction indicating that
iron-driven effects are at least in part responsible for the observed
effects (Fig 3B).
Dissolved and cellulose-coupled DFO reduced the iron-
driven increase in lipid peroxidation Using the in vitro
setting with Fe(III) citrate and ascorbate to simulate conditions of
chronic venous leg ulcers, we have studied the effect of dissolved
and cellulose-coupled DFO on lipid peroxidation. The Fe(III)
citrate, ascorbate driven Fenton reaction resulted in a 5-fold
increase in MDA, the major product of lipid peroxidation, as
determined by HPLC based methods. This increase in MDA levels
could be signi®cantly reduced in the presence of dissolved DFO
(Fig 4A) or the pick-up dressing coupled with DFO (Fig 4B)
clearly indicating the functionality of dissolved and cellulose-
coupled DFO.
DISCUSSION
Venous leg ulcers are common and cause considerable morbidity in
the adult population. As healing may be slow or may never be
achieved, ulcers create persistent and substantial demands on
resources. A wide variety of dressings have been used, but to date
there is no dressing on the market that can claim to signi®cantly
enhance tissue repair. This may at least partly be due to the limited
knowledge on the microenvironment of chronic wounds. In fact,
Figure 3. Dissolved and cellulose-coupled DFO suppresses the
iron-driven induction of interstitial collagenase (MMP-1).
Con¯uent monolayer cultures of human dermal ®broblasts were exposed
for 4 h to a combination of Fe(III) citrate at a concentration of 220 mM
and ascorbate at a concentration of 1 mM in the absence and presence of
dissolved DFO (220 mM) (A), an equimolar amount of DFO
immobilized to cellulose, or control cellulose without DFO (B) as
detailed in Materials and Methods. Thereafter, cells were washed and after
an incubation period of 24 h supernatants were collected and subjected
to an MMP-1 speci®c ELISA. Three independent experiments have
been performed in triplicate. Each bar represents the mean of a
representative experiment with standard deviation. *p = 0.0002 (A); *p
= 0.0247, #p = 0.0026 (B) compared with cells exposed to Fe(III)
citrate/ascorbate (Student's t test).
Figure 2. Effective reduction of iron ions in iron solution by
gamma-sterilized DFO±cellulose. In order to determine the iron
binding capacity of active functional DFO-coupled cellulose and
placebo±cellulose, we have used the iron pick-up assay as detailed in
Materials and Methods. Brie¯y, 15 mg of cellulose sample (placebo or
DFO verum) were added to 40 ml FeSO4 solution at an initial
concentration of 47 mM (ratio DFO:Fe = 1.5:2.0). The concentration of
iron was determined in the supernatants before and after addition of
cellulose samples as detailed in Materials and Methods. The results were
expressed as mmol per l. Three independent experiments were performed
in triplicate. Each point represents the mean value with standard
deviation.
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the tremendous impact of the microenvironmental conditions on
the outcome of wound healing has increasingly become apparent.
Several comprehensive studies demonstrate that the proteolytic
activity of matrix metalloproteinases and serine proteases is
signi®cantly upregulated in the exudate of chronic wounds
(Grinnell et al, 1992; Wysocki et al, 1993; Rao et al, 1995;
Grinnell and Zhu, 1996; Mast and Schultz, 1996; Weckroth et al,
1996; Herrick et al, 1997; Saarialho-Kere, 1998), thus contributing
to the degradation of the extracellular matrix (Grinnell et al, 1992),
growth factors (Wlaschek et al, 1997; Yager et al, 1997; Lauer et al,
2000) and potentially their receptors.
In this study we have ®rst focused on the identi®cation of
potential deleterious factors that contribute to the prooxidant
hostile microenvironment of chronic leg ulcers. Based on our
®ndings with enhanced iron levels in the exudates of chronic
wounds, we have designed and developed a novel iron chelating
and reactive oxygen scavenging dressing with DFO-coupled
cellulose and have subsequently evaluated this iron-selective pick-
up dressing for its ef®cacy and functionality in several in vitro assays
closely simulating prooxidant conditions in chronic venous leg
ulcers.
We report here that total iron concentrations in exudates from
chronic venous ulcers are signi®cantly elevated compared to iron
concentrations in acute wound ¯uids. This is not unexpected, as
increased iron levels in ulcer tissue have been reported earlier
(Ackerman et al, 1988). Moreover, it is known that ROS and
proteases are able to release iron from different iron-containing
proteins (Thomas et al, 1985; Biemond et al, 1988; Fridovich, 1995)
most probably enhancing the transfer of iron from the tissue into
the exudate. Due to low available amounts of ulcer ¯uid, only total
iron contents have been measured. Using potentiometric stripping
analysis that allows a distinction between different species of iron
complexes, Liyanage et al (1996) found that in not further speci®ed
wounds almost no free iron ions can be detected. According to
these authors, a considerable amount, 18%, of iron binds to citrate
naturally occurring in plasma and presumably in wound ¯uid, too.
Because the ferric iron binding constant of DFO (1031) is much
higher than that of citrate (1010.5) (KoÈnigsberger et al, 2000), DFO
should be able to preferentially extract ferric iron from citrate-
coupled complexes. Furthermore, it is well documented that DFO
is able to extract and subsequently bind iron ions from ferritin and
in part also from transferrin (Keberle, 1964).
Increased iron levels in the exudate of chronic wounds and its
iron-catalyzed toxicity with the generation of the highly aggressive
hydroxyl radical may causally contribute to severe tissue damage
most extensively observed in super®cial layers of the ulcer base.
The causal role of the iron-driven generation of hydroxyl radicals
in venous ulceration and its persistence is substantiated by a clinical
study with 133 enrolled patients that convincingly demonstrates
that topical application of powder containing hydroxyl radical
scavenging dimethylsulfoxide or the xanthine oxidase inhibitor
allopurinol signi®cantly stimulates the healing rate of venous leg
ulcers (Salim, 1991). This author did not identify increased iron
levels to be involved in the pathogenic sequence underlying
impaired tissue repair, however.
In fact, the detrimental effects of increased free iron and its
damaging effects have clearly been shown in primary and secondary
hemochromatosis, thalassemia, and congenital hemolytic anemia,
particularly in the heart. A signi®cant positive correlation between
the extent of cardiac iron deposits and cardial dysfunction and
failure has been documented (Buja and Roberts, 1971; Zeimer et al,
1978; Motulsky, 1985). Furthermore, increased iron levels are
thought to play a causal role in the progression of osteoarthritis
(Okazaki et al, 1981; Blake et al, 1984), injury of the spinal cord
(Zhang et al, 1996), and extrinsic skin aging (Bissett et al, 1990;
Brenneisen et al, 1998). Interestingly, experimental and clinical
studies demonstrate that iron chelation by DFO substantially
protects the myocardial ®bers against iron-dependent damage
(Grisaru et al, 1986) and decreases necrosis in dorsally localized pig
skin ¯aps (Weinstein et al, 1989). As iron in conjunction with
H2O2 and O2
±´ generated by activated neutrophils and ± under
hypoxic conditions ± by xanthine oxidase most probably drives the
toxicity underlying persistent ulceration, we have set out to design
an iron chelating dressing with antioxidant properties potentially
disrupting this detrimental sequence of events. Among several iron
Figure 4. Dissolved and cellulose-coupled DFO reduces the iron-
driven increase in lipid peroxidation. Con¯uent monolayer cultures
of human dermal ®broblasts were exposed to a combination of Fe(III)
citrate at a concentration of 220 mM and ascorbate at a concentration of
1 mM in the absence and presence of dissolved DFO (220 mM) (A), an
equimolar amount of DFO immobilized to cellulose, and control
cellulose without DFO (B) as detailed in Materials and Methods. The
major product of lipid peroxidation, MDA, was measured in cell lysates
using established procedures as detailed in Materials and Methods. MDA
concentrations are expressed per mg protein. Three independent
experiments in triplicate were performed to determine MDA
concentrations. Each bar represents the mean of a representative
experiment with standard deviation. *p = 0.0019 (A); *p = 0.0135 (B)
compared to Fe(III) citrate/ascorbate treated cells (Student's t test).
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chelators, DFO is the most speci®c and potent, with a stability
constant of 1031 (Keberle, 1964). Furthermore, DFO has been
extensively studied in a variety of experimental and clinical settings
with well-established ef®cacy and toxicity pro®les (BeDell and
Hulbert, 1999; Dollery, 1999).
We report here on the activation of functional groups of the
cellulose dressing and successful covalent coupling of DFO to a
cellulose dressing. As a result, approximately 2 mmol DFO were
covalently bound per square centimeter of cellulose dressing,
providing an iron complexing capacity suf®cient to cope with the
iron levels found in chronic venous leg ulcers. Furthermore, it
could be shown that DFO±cellulose is able to bind iron out of a
BSA-containing iron solution as an arti®cial chronic wound ¯uid.
As stability after gamma sterilization represents an important
prerequisite for a dressing, leakage of gamma-sterilized DFO-
coupled cellulose was analyzed. No leakage of DFO or its
breakdown products from the dressing was detected. This is in
line with data from the literature on the extraordinary stability of
urethane bonds (Bethell and Ayers, 1981).
As connective tissue breakdown and lipid peroxidation represent
pathogenic hallmarks preventing healing of chronic venous leg
ulcers, we established a model that closely simulates the iron-driven
Fenton reaction. Using this model system, we have screened
dissolved and cellulose-bound DFO for their protecting properties
from Fe(III) citrate/ascorbate driven upregulation of MMP-1, the
major metalloproteinase in connective tissue breakdown, and
enhanced lipid peroxidation. We found that exposure of ®broblasts
to the Fenton reaction mimicking combination of 220 mM Fe(III)
citrate and 1 mM ascorbate resulted in a 4-fold induction of MMP-
1 levels. This induction was almost completely suppressed by
dissolved DFO at a concentration of 220 mM or the equimolar
amount of DFO covalently coupled to cellulose.
In addition, the Fe(III) citrate/ascorbate driven Fenton reaction
resulted in a 5-fold increase in MDA, the major product of lipid
peroxidation. The increase in MDA levels could be signi®cantly
reduced in the presence of dissolved DFO or DFO-coupled
cellulose. Collectively, these data indicate that DFO in its dissolved
or bound form effectively prevents the development of a
prooxidant microenvironnment and, furthermore, protects from
unfavorable consequences like MMP-1 and lipid peroxide induc-
tion. We anticipate that the protective effect of DFO by the above
mentioned mechanisms limits tissue injury and the perpetuated
recruitment of activated neutrophils characteristic for chronic
venous leg ulcers. In fact, in a TPA (12-O-tetradecanoyl-phorbol-
13-acetate) induced in¯ammation model, topical application of
DFO prior to TPA treatment could almost completely inhibit the
neutrophil in¯ux into the interstitial tissue of mouse ears (Soybir
et al, 1996).
Based on our promising results a double blind placebo controlled
clinical study has been started to prove the principle and assess the
therapeutic value for patients suffering from nonhealing wounds.
We gratefully acknowledge the stimulating discussion with Cecilia Welling.
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